CGEM vs REGN: Which Stock is Better?

Side-by-side comparison of Cullinan Therapeutics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CGEM

Cullinan Therapeutics Inc

$15.06

REGN

Regeneron Pharmaceuticals Inc

$750.57

Key Metrics Comparison

MetricCGEMREGNWinner
Market Cap$892.16M$78.87BREGN
P/E RatioN/A17.98REGN
EPS (TTM)$N/A$41.48REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze CGEM

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CGEM or REGN a better investment?

Comparing CGEM and REGN: Cullinan Therapeutics Inc has a market cap of $892.16M while Regeneron Pharmaceuticals Inc has $78.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CGEM and REGN?

CGEM (Cullinan Therapeutics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CGEM or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CGEM or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for CGEM.

Which company is more profitable: CGEM or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for CGEM.

Which is the larger company: CGEM or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.87B compared to $892.16M for CGEM.

Should I buy CGEM or REGN in 2026?

Both CGEM and REGN have investment merit. CGEM trades at $15.06 while REGN trades at $750.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CGEM and REGN stock?

Key differences: Market Cap ($892.16M vs $78.87B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons